Monday, June 15, 2026

HomeHealth NewsFDA approves first AI test to guide breast cancer chemotherapy decisions

FDA approves first AI test to guide breast cancer chemotherapy decisions

- Advertisement -

The AI platform could help clinicians with treatment options for those with early-stage, HR+, HER2-negative invasive breast cancer. Image credit: Fly View Productions/Getty Images
  • According to estimates from 2022, about 2.3 million females around the world were newly diagnosed with breast cancer.
  • Depending on the type of breast cancer, treatment options may include chemotherapy.
  • Different types and stages of breast cancer have different rates for recurrence and metastasis.
  • The U.S. FDA recently…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed